COMPARISON OF OUTCOME OF CLOMIPHENE CITRATE ALONE AND IN COMBINATION WITH PIOGLITAZONE FOR INDUCTION OF OVULATION IN INFERTILE WOMEN WITH POLYCYSTIC OVARIAN SYNDROMECOMPARISON OF OUTCOME OF CLOMIPHENE CITRATE ALONE AND IN COMBINATION WITH PIOGLITAZON

Introduction: Polycystic ovarian syndrome (PCOS) is a common endocrine condition and a primary contributor to infertility in women of reproductive age. Clomiphene citrate (CC) serves as a primary intervention for ovulation induction; yet, its effectiveness may be constrained in certain cases.Objectives: To compare the outcome of ovulation induction in clomiphene citrate (CC) alone and combined treatment with CC and pioglitazone in terms of mean maximum follicle size among infertile women with PCOS.Material and Methods: This randomized controlled trial was conducted at the Gynecology and Obstetrics Department, DHQ Teaching Hospital Rawalpindi, from August 2024 to February 2025.A total of 274 married women with PCOS and infertility were enrolled and randomized into two groups: Group A (CC alone, n=137) and Group B (CC + pioglitazone, n=137). Ultrasonographic folliculometry was performeduntil mature follicles were detected. Inj.hCG (10,000 IU) was given intramuscularly when at least one follicle ≥18 mm was formed in either ovary.Mean maximum follicle size was recorded over three menstrual cycles. Data were analyzed using SPSS.Results: The mean maximum follicle size was significantly larger in Group B (21.48 ± 2.26 mm) compared to Group A (18.53 ± 3.31 mm, p<0.001). Subgroup analyses confirmed the superiority of the combined treatment across age, BMI, residential status, duration of marriage, and type of infertility.Conclusion:The combination of pioglitazone withCC markedly improves follicular development in infertile patients with PCOS. This combination provides a relativelyeconomical and attainable treatment approach, especially advantageous for resource-constrained environments. Additional research is required to assess long-term effects and safety profiles.Keywords: PCOS, Infertility, Follicle Size, Ovulation, Clomiphene Citrate, Pioglitazone

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-10
DOI
https://doi.org/10.5281/zenodo.14620521
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COMPARISON OF OUTCOME OF CLOMIPHENE CITRATE ALONE AND IN COMBINATION WITH PIOGLITAZONE FOR INDUCTION OF OVULATION IN INFERTILE WOMEN WITH POLYCYSTIC OVARIAN SYNDROMECOMPARISON OF OUTCOME OF CLOMIPHENE CITRATE ALONE AND IN COMBINATION WITH PIOGLITAZON

Zenodo (CERN European Organization for Nuclear Research)
Ovarian function and disorders
article

COMPARISON OF OUTCOME OF CLOMIPHENE CITRATE ALONE AND IN COMBINATION WITH PIOGLITAZONE FOR INDUCTION OF OVULATION IN INFERTILE WOMEN WITH POLYCYSTIC OVARIAN SYNDROMECOMPARISON OF OUTCOME OF CLOMIPHENE CITRATE ALONE AND IN COMBINATION WITH PIOGLITAZON

article en

Abstract

Introduction: Polycystic ovarian syndrome (PCOS) is a common endocrine condition and a primary contributor to infertility in women of reproductive age. Clomiphene citrate (CC) serves as a primary intervention for ovulation induction; yet, its effectiveness may be constrained in certain cases.Objectives: To compare the outcome of ovulation induction in clomiphene citrate (CC) alone and combined treatment with CC and pioglitazone in terms of mean maximum follicle size among infertile women with PCOS.Material and Methods: This randomized controlled trial was conducted at the Gynecology and Obstetrics Department, DHQ Teaching Hospital Rawalpindi, from August 2024 to February 2025.A total of 274 married women with PCOS and infertility were enrolled and randomized into two groups: Group A (CC alone, n=137) and Group B (CC + pioglitazone, n=137). Ultrasonographic folliculometry was performeduntil mature follicles were detected. Inj.hCG (10,000 IU) was given intramuscularly when at least one follicle ≥18 mm was formed in either ovary.Mean maximum follicle size was recorded over three menstrual cycles. Data were analyzed using SPSS.Results: The mean maximum follicle size was significantly larger in Group B (21.48 ± 2.26 mm) compared to Group A (18.53 ± 3.31 mm, p<0.001). Subgroup analyses confirmed the superiority of the combined treatment across age, BMI, residential status, duration of marriage, and type of infertility.Conclusion:The combination of pioglitazone withCC markedly improves follicular development in infertile patients with PCOS. This combination provides a relativelyeconomical and attainable treatment approach, especially advantageous for resource-constrained environments. Additional research is required to assess long-term effects and safety profiles.Keywords: PCOS, Infertility, Follicle Size, Ovulation, Clomiphene Citrate, Pioglitazone

Zenodo (CERN European Organization for Nuclear Research)
Gender equality
Openalex Percentile: Top 59%
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.